custom image

Joint meeting with Hepatobiliary Cancers: Pathobiology and Translational Advances

Fatty Liver Disease and Multi-System Complications

March 22-24, 2021 | 10:00AM EDT | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change



Joint Meetings

Your registration provides you with access to both the “Fatty Liver Disease and Multi-System Complications” and “Hepatobiliary Cancers: Pathobiology and Translational Advances” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!

  View Joint Meeting On Demand Content



Reset

Advanced Filters
10:00am - 11:10am EDT - March 22, 2021 | Room: Multi Tech Session
Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center; Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: [Joint Session] Welcoming Remarks and Keynote Session

Monday
10:00am - 10:35am EDT - March 22, 2021 | Room: V100 Atticus Kiser
Helen H. Hobbs, MD, University of Texas Southwestern Medical Center
Track: [Joint Session] Welcoming Remarks and Keynote Session

Monday
10:35am - 11:10am EDT - March 22, 2021 | Room: V100 Atticus Kiser
Hashem B. El-Serag, MD, Baylor College of Medicine
Track: [Joint Session] Welcoming Remarks and Keynote Session

11:10am - 01:00pm EDT - March 22, 2021 | Room: Multi Tech Session
Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center; Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Monday
11:10am - 11:35am EDT - March 22, 2021 | Room: V300 Guy Coombes
Lopa Mishra, MD, George Washington University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Monday
11:55am - 12:20pm EDT - March 22, 2021 | Room: V200 Ronney Laws
Maria Rescigno, PhD, Humanitas University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Monday
12:20pm - 12:45pm EDT - March 22, 2021 | Room: V200 Ronney Laws
Daniel A. Heller, PhD, Memorial Sloan Kettering Cancer Center
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Monday
12:45pm - 01:00pm EDT - March 22, 2021 | Room: V200 Ronney Laws
Juan R. Sanabria, MD, Marshall University/Case Western Reserve University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Monday
02:30pm - 03:30pm EDT - March 22, 2021
Kendra K. Bence, PhD, Panelist, Pfizer Inc.; Augusto Villanueva Rodriguez, MD, PhD, Panelist, Icahn School of Medicine at Mount Sinai; Xin Wei Wang, PhD, Panelist, NCI, National Institutes of Health
Track: Career Roundtable

05:00pm - 07:10pm EDT - March 22, 2021 | Room: Multi Tech Session
Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center; Henry N. Ginsberg, MD, Co-Chair, Columbia University Vagelos College of Physicians and Surgeons
Track: Genetics of NAFLD

Monday
05:00pm - 05:25pm EDT - March 22, 2021 | Room: V100 Atticus Kiser
Elizabeth K. Speliotes, MD, PhD, University of Michigan
Track: Genetics of NAFLD

Monday
05:25pm - 05:50pm EDT - March 22, 2021 | Room: V100 Atticus Kiser
Noura S. Abul-Husn, MD, PhD, Icahn School of Medicine at Mount Sinai
Track: Genetics of NAFLD

Monday
05:50pm - 06:05pm EDT - March 22, 2021 | Room: V100 Atticus Kiser
Karthickeyan Chella Krishnan, PhD, University of Cincinnati
Track: Genetics of NAFLD

Monday
06:05pm - 06:20pm EDT - March 22, 2021 | Room: V100 Atticus Kiser
Mohammad Kabbani, MD, Rockefeller University
Track: Genetics of NAFLD

Monday

Monday
06:55pm - 07:10pm EDT - March 22, 2021 | Room: V600 Zach Smith
Neil A. Youngson, BS, Institute of Hepatology
Track: Genetics of NAFLD

07:10pm - 08:00pm EDT - March 22, 2021 | Room: Multi Tech Session
Henry N. Ginsberg, MD, Co-Chair, Columbia University Vagelos College of Physicians and Surgeons; Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center
Track: NAFLD and CVD

Monday
07:10pm - 07:35pm EDT - March 22, 2021 | Room: V500 Travis Lodolinski
Henry N. Ginsberg, MD, Columbia University Vagelos College of Physicians and Surgeons
Track: NAFLD and CVD

Monday
07:35pm - 08:00pm EDT - March 22, 2021 | Room: V500 Travis Lodolinski
Jay D. Horton, MD, University of Texas Southwestern Medical Center
Track: NAFLD and CVD

10:00am - 01:00pm EDT - March 23, 2021 | Room: Multi Tech Session
Catherine Postic, PhD, Co-Chair, INSERM Institut Cochin; Hannele Yki-Järvinen, MD, PhD, Co-Chair, University of Helsinki
Track: Role of Lipids in NAFLD

Tuesday
10:00am - 10:25am EDT - March 23, 2021 | Room: V500 Travis Lodolinski
Mitchell A. Lazar, MD, PhD, Perelman School of Medicine, University of Pennsylvania
Track: Role of Lipids in NAFLD

Tuesday
10:25am - 10:50am EDT - March 23, 2021 | Room: V500 Travis Lodolinski
Catherine Postic, PhD, INSERM Institut Cochin
Track: Role of Lipids in NAFLD

Tuesday
10:50am - 11:15am EDT - March 23, 2021 | Room: V500 Travis Lodolinski
Hannele Yki-Järvinen, MD, PhD, University of Helsinki
Track: Role of Lipids in NAFLD

Tuesday
11:35am - 12:00pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Eran Elinav, MD, PhD, Weizmann Institute of Science
Track: Role of Lipids in NAFLD

Tuesday
12:00pm - 12:15pm EDT - March 23, 2021 | Room: V200 Ronney Laws
HongMin Ni, MD, University of Kansas Medical Center
Track: Role of Lipids in NAFLD

Tuesday
12:15pm - 12:30pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Joanne Hsieh, PhD, Columbia University
Track: Role of Lipids in NAFLD

Tuesday
12:30pm - 12:45pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Xiao-Wei Chen, PhD, Peking University
Track: Role of Lipids in NAFLD

Tuesday
12:45pm - 01:00pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Zhaoyue Zhang, MS, Princeton University
Track: Role of Lipids in NAFLD

Tuesday
02:30pm - 03:30pm EDT - March 23, 2021
Elena Bellafante, Panelist, Med- Cell Press; Francesco Giovinazzo, Panelist, Frontiers; Xin (Cindy) Sun, PhD, Panelist, Journal of Experimental Medicine (JEM)
Track: Meet the Editors Roundtable

05:00pm - 07:45pm EDT - March 23, 2021 | Room: Multi Tech Session
Morris J. Birnbaum, MD, PhD, Co-Chair, Pfizer Inc.; Tobias C. Walther, PhD, Co-Chair, Harvard School of Public Health
Track: Pathways to NASH

Tuesday
05:00pm - 05:25pm EDT - March 23, 2021 | Room: V400 Ryan Reid
Mark A. McNiven, PhD, Mayo Clinic
Track: Pathways to NASH

Tuesday
05:25pm - 05:50pm EDT - March 23, 2021 | Room: V400 Ryan Reid
Tobias C. Walther, PhD, Harvard School of Public Health
Track: Pathways to NASH

Tuesday
05:50pm - 06:05pm EDT - March 23, 2021 | Room: V400 Ryan Reid
Annelise Poss, BS, University of Utah
Track: Pathways to NASH

Tuesday
06:30pm - 06:45pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Cholsoon Jang, PhD, University of California, Irvine
Track: Pathways to NASH

Tuesday
06:45pm - 07:00pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Kahealani Uehara, BS, University of Pennsylvania
Track: Pathways to NASH

Tuesday
07:00pm - 07:15pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Sabine Daemen, PhD, Washington University in St. Louis
Track: Pathways to NASH

Tuesday
07:15pm - 07:30pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Track: Pathways to NASH

Tuesday
07:30pm - 07:45pm EDT - March 23, 2021 | Room: V200 Ronney Laws
Wenke Jonas, PhD, German Institute of Human Nutrition
Track: Pathways to NASH

10:00am - 01:25pm EDT - March 24, 2021 | Room: Multi Tech Session
Hannele Yki-Järvinen, MD, PhD, Co-Chair, University of Helsinki; Morris J. Birnbaum, MD, PhD, Co-Chair, Pfizer Inc.
Track: Emerging Therapies for NASH

Wednesday
10:00am - 10:25am EDT - March 24, 2021 | Room: V400 Ryan Reid
Track: Emerging Therapies for NASH

Wednesday
10:25am - 10:50am EDT - March 24, 2021 | Room: V400 Ryan Reid
Chuhan Chung, MD, Gilead Sciences
Track: Emerging Therapies for NASH

Wednesday
10:50am - 11:15am EDT - March 24, 2021 | Room: V400 Ryan Reid
Greg Steinberg, PhD, McMaster University
Track: Emerging Therapies for NASH

Wednesday
11:15am - 11:40am EDT - March 24, 2021 | Room: V400 Ryan Reid
Kendra K. Bence, PhD, Pfizer Inc.
Track: Emerging Therapies for NASH

Wednesday
11:50am - 12:15pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Lei Ling, PhD, NGM Biopharmaceuticals
Track: Emerging Therapies for NASH

Wednesday
12:15pm - 12:30pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Aimee L. Edinger, PhD, University of California, Irvine
Track: Emerging Therapies for NASH

Wednesday
12:30pm - 12:45pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Brian Rady, Janssen R&D
Track: Emerging Therapies for NASH

Wednesday
12:45pm - 01:00pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Haressh Sajiir, University of Queensland - Mater Research Institute
Track: Emerging Therapies for NASH

Wednesday
01:00pm - 01:15pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Madhulika Tripathi, PhD, Duke-NUS Medical School Singapore
Track: Emerging Therapies for NASH

Wednesday
01:15pm - 01:25pm EDT - March 24, 2021 | Room: V200 Ronney Laws
Track: Emerging Therapies for NASH